UiPath Positioned as a Leader in the Gartner Inaugural Magic Quadrant for Intelligent Document Processing
PATH(NYSE:PATH) NEW YORK--(BUSINESS WIRE)--UiPath announced its positioning as a Leader in the inaugural Gartner® Magic Quadrant™ for Intelligent Document Processing (IDP).
UiPath Reports Second Quarter Fiscal 2026 Financial Results
PATH(NYSE:PATH) NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its second quarter fiscal 2026 ended July 31, 2025. “We delivered a strong second quarter with ARR growing 11% year-over-year to $1.723 billion, reflecting the team’s improved execution and the growing momentum of our agentic capabilities,” said Daniel Dines, UiPath Founder and Chief Executive Officer. "Our continued innovation and best-in-class products are enablin
UiPath Appoints Michael Atalla as Chief Marketing Officer to Drive Leadership in Agentic AI and Orchestration
PATHNEW YORK--(BUSINESS WIRE)--UiPath, a global leader in agentic automation, today announced the appointment of Michael Atalla as its new Chief Marketing Officer. Atalla will oversee all facets of the company’s global marketing strategy – including brand, performance, demand generation, and communications – playing a central role in elevating UiPath’s leadership in agentic AI and orchestration, delivering high-impact solutions, powered by agentic automation, to transform complex business processes
UiPath Announces Second Quarter Fiscal 2026 Financial Results Conference Call
PATHNEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced it will report financial results for its second quarter fiscal 2026 ended July 31, 2025 after the market closes on Thursday, September 4, 2025. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Second Quarter Fiscal 2026 Financial Results Conference Call When: Thursday, September 4, 2025 Time: 5:00 pm ET Conference ID: 137
Morgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $15
PATHHCLTech and UiPath Announce Strategic Partnership To Drive Large-Scale Transformation For Enterprises Across Industries
PATHCanaccord Genuity Maintains Buy on UiPath, Raises Price Target to $16
PATHAnalysts Applaud UiPath's AI Traction, But Net New ARR Slide Sparks Caution
PATHUiPath reports strong Q1 results, raises FY26 guidance, and sees early success with agentic AI initiatives. Analysts increase price targets.
BMO Capital Maintains Market Perform on UiPath, Raises Price Target to $15.5
PATHEvercore ISI Group Maintains In-Line on UiPath, Raises Price Target to $15
PATHThese Analysts Boost Their Forecasts On UiPath After Upbeat Q1 Results
PATHTruist Securities Maintains Hold on UiPath, Raises Price Target to $13
PATHBarclays Maintains Equal-Weight on UiPath, Raises Price Target to $14
PATHDA Davidson Maintains Neutral on UiPath, Raises Price Target to $14
PATHScotiabank Maintains Sector Perform on UiPath, Raises Price Target to $13
PATHRBC Capital Maintains Sector Perform on UiPath, Raises Price Target to $15
PATHWells Fargo Maintains Equal-Weight on UiPath, Raises Price Target to $12
PATHUiPath Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
PATHNeedham Reiterates Hold on UiPathto Hold
PATHUiPath Stock Surges On Q1 Earnings Beat, Raised Guidance: 'This Was A Milestone Quarter'
PATHUiPath Inc (NYSE:PATH) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected results for the first quarter and raised its full-year outlook.
UiPath Raises FY2026 Sales Guidance from $1.52B-$1.53B to $1.549B-$1.554B vs $1.53B Est
PATHUiPath Sees Q2 Sales $345.000M-$350.000M vs $333.12M Est
PATHUiPath Q1 Adj. EPS $0.11 Beats $0.10 Estimate, Sales $356.62M Beat $332.87M Estimate
PATHA Look at UiPath's Upcoming Earnings Report
PATHRedis And UiPath Have Expanded Their Collaboration Toward Furthering Agentic Automation Solutions For Customers
PATHMizuho Maintains Neutral on UiPath, Lowers Price Target to $11
PATHIs the Market Bullish or Bearish on UiPath?
PATHRBC Capital Reiterates Sector Perform on UiPath, Maintains $13 Price Target
PATHNeedham Reiterates Hold on UiPathto Hold
PATH'Coronis Health Enhances Healthcare Delivery Systems Through UiPath Platform' - UiPath
PATHBMO Capital Maintains Market Perform on UiPath, Lowers Price Target to $11.5
PATHUiPath Shares Drop After Q4 Revenue Miss And Weak Q1 Guidance: What's Going On?
PATHUiPath, Inc. (NYSE: PATH) shares are trading lower Thursday after the company reported fourth-quarter revenue and issued lower-than-expected revenue guidance for the first quarter.
UiPath Hit By Slowing ARR Growth, Deal Timing Woes: Analyst Remains Optimistic For AI, Cloud Spark
PATHUiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and uncertainty in US Fed segment.
UiPath Stock Down: Faces Caution Despite Margin Gains, Analyst Doubtful About Company's AI Transition Capability
PATHUiPath's Q4 results show margin improvements, but analyst cautions on AI transition and growth pressure, lowering price target to $12.
RBC Capital Maintains Sector Perform on UiPath, Lowers Price Target to $13
PATHCanaccord Genuity Maintains Buy on UiPath, Lowers Price Target to $14
PATHEvercore ISI Group Maintains In-Line on UiPath, Lowers Price Target to $12
PATHScotiabank Maintains Sector Perform on UiPath, Lowers Price Target to $12
PATHUBS Maintains Sell on UiPath, Lowers Price Target to $10
PATHWells Fargo Maintains Equal-Weight on UiPath, Lowers Price Target to $11
PATHBarclays Maintains Equal-Weight on UiPath, Lowers Price Target to $12
PATHMizuho Maintains Neutral on UiPath, Lowers Price Target to $12
PATHThe Analyst Verdict: UiPath In The Eyes Of 3 Experts
PATHMorgan Stanley Maintains Equal-Weight on UiPath, Lowers Price Target to $12
PATHNeedham Reiterates Hold on UiPathto Hold
PATHB of A Securities Downgrades UiPath to Underperform, Lowers Price Target to $10
PATHUiPath Shares Plunge After Q4 Revenues Miss, Weak Q1 Guidance
PATHUiPath releases its fourth-quarter results after Wednesday's closing bell. Here's a look at the key figures from the report.
UiPath Sees Q1 Revenue $330M-$335M Vs $368.086M Est.
PATHUiPath Q4 2025 GAAP EPS $0.09 Beats $0.03 Estimate, Sales $424.000M Miss $425.361M Estimate
PATHUiPath Enters Into New Global Consulting Agreement With Major EMR Platform, Expanding Services In 16 Countries
PATH